Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Camilleri, MD
GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in Rochester, Minnesota, to discuss key findings on gastrointestinal side effects, procedural risks, and the impacts of GLP-1 receptor agonists on the fields of gastroenterology and hepatology.
-------- Â
--------
Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Camilleri, MD
GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in Rochester, Minnesota, to discuss key findings on gastrointestinal side effects, procedural risks, and the impacts of GLP-1 receptor agonists on the fields of gastroenterology and hepatology.
-------- Â
--------
Optimizing Nutrition in Patients with Chronic Liver Disease
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Ashwani K. Singal MD, MS, FACG, FAASLD, AGAF
Sarcopenia and poor nutrition are often silent threats in chronic liver disease, yet they drastically impact outcomes. Joining Dr. Peter Buch to discuss strategies for recognizing and addressing malnutrition early to improve long-term liver health is Dr. Ashwani Singal. Dr. Singal is a Professor of Medicine at the University of Louisville School of Medicine.
-------- Â
--------
Optimizing Nutrition in Patients with Chronic Liver Disease
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Ashwani K. Singal MD, MS, FACG, FAASLD, AGAF
Sarcopenia and poor nutrition are often silent threats in chronic liver disease, yet they drastically impact outcomes. Joining Dr. Peter Buch to discuss strategies for recognizing and addressing malnutrition early to improve long-term liver health is Dr. Ashwani Singal. Dr. Singal is a Professor of Medicine at the University of Louisville School of Medicine.
-------- Â
--------
Tailoring Inflammatory Bowel Disease Care: Selection Criteria and Timing
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Fudman, MD
As the advanced treatment landscape for inflammatory bowel disease continues to expand, selecting the right therapies has become more complex, with efficacy, safety, patient preferences, disease phenotypes, and more as factors to consider. Learn how to effectively navigate these therapeutic options for ulcerative colitis and Crohn’s disease with Dr. Peter Buch and Dr. David Fudman, Assistant Professor and Director of Inflammatory Bowel Disease Clinics at the University of Texas Southwestern Medical Center.
Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.
South Africa